Market Cap 2.04B
Revenue (ttm) 10.27B
Net Income (ttm) 157.00M
EPS (ttm) N/A
PE Ratio 1.35
Forward PE 1.30
Profit Margin 1.53%
Debt to Equity Ratio -19.19
Volume 1,037,200
Avg Vol 1,624,830
Day's Range N/A - N/A
Shares Out 373.81M
Stochastic %K 27%
Beta 0.42
Analysts Hold
Price Target $7.50

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. T...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 514 744 6792
Address:
2150 St. Elzéar Blvd. West, Laval, Canada
Rpate
Rpate May. 14 at 3:57 PM
$BHC BLCO showed negative free cash flow in Q1 2026 after two consecutive quarter of positive free cash flow. Now it may be possible BLCO can show negative free cash flow even after $7B revenue in 2028. Lot of noise about growth without positive free cash flow.
0 · Reply
Glene
Glene May. 14 at 12:30 AM
$BHC $DRRX how much are you figuring per share?
1 · Reply
bigbulldaddy
bigbulldaddy May. 13 at 11:02 PM
$BHC $DRRX Currently as of May Larsucosterol trial has 5/48 sites recruiting for 350 patient phase 3. Heads up to my people we are starting to move. Hope it’s quick. Good luck my LONG token holders… I did the math for myself: Assuming google is right I’m expecting… $288,000 at 500 million in sales $384,000 at 1 billion in sales Bausch is also looking at other R&D targets for Larsucosterol per info which we don’t get any money on… lol they literally called it REAHFIRM
1 · Reply
brunoq14
brunoq14 May. 13 at 2:51 AM
$BHC https://clinicaltrials.gov/study/NCT07428538 Three additional sites have begun recruiting for the larsucosterol trial, in Baltimore, Houston, and Richmond, joining Dallas and Charleston to make five in all. 48 sites are planned. Most recent update: 05/07/2026
0 · Reply
FU2
FU2 May. 11 at 10:44 PM
$BHC just total fuckery, heading to $5 again. Option traders are in full control. Hate these MM's to the core.
0 · Reply
truckersam
truckersam May. 11 at 8:27 PM
$BHC put 500,000 back in, we need the action 😁
0 · Reply
Bobberty
Bobberty May. 11 at 7:40 PM
$BHC and going sub $5 again. What a dumbass I am, should have kept it all in UNH. Oh well, get to enjoy the Canadian healthcare investment journey again.
0 · Reply
AnthonyNicholas
AnthonyNicholas May. 11 at 7:28 PM
$BHC what now why are we down so much today? 
0 · Reply
btradingwarehouse
btradingwarehouse May. 11 at 5:40 PM
$BHC ...2BULLS... ... ...Warriors ...We "lost" one of the most persistent bull (@SellSalix) ...His very classy update will be remembered ... ...Let's do quick reminder: ...You are NOT buying this beauty !!! ...Do NOT try to average unless you are trader (very good one) !!! ...You are NOT selling this beauty !!! ...Watch for BLCO ... Stay smart strong smile (if you can ?!)
0 · Reply
SellSalix
SellSalix May. 8 at 4:05 PM
$BHC it’s been a while, so I thought I would just update everyone. I sold this POS at a huge loss; about $500K. The opportunity cost on this probably adds another $500K (so, I effectively lost about a $1M). This is by far the worst investment I’ve ever made and it has scarred me for life. I did, however, end up buying long term calls at $5 and $10. If you are considering buying this stock, DON’T DO IT! Instead, buy call options that expire in a year or so. This is the only way to play this stock. I believe this will eventually re-rate once market comes to realize they will survive and monetize BLCO
8 · Reply
Latest News on BHC
Bausch Health Companies Earnings Call Transcript: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 16 days ago

Bausch Health Companies Earnings Call Transcript: Q1 2026


Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c

2026-04-29T20:33:36.000Z - 16 days ago

Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c


BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS

Apr 29, 2026, 4:05 PM EDT - 16 days ago

BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS


Bausch Health price target lowered to $7 from $8 at Barclays

2026-02-25T10:15:55.000Z - 2 months ago

Bausch Health price target lowered to $7 from $8 at Barclays


Bausch Health Companies Earnings Call Transcript: Q4 2025

Feb 18, 2026, 5:00 PM EST - 3 months ago

Bausch Health Companies Earnings Call Transcript: Q4 2025


Bausch Health reports Q4 EPS (30c) vs. 25c a year ago

2026-02-18T21:21:45.000Z - 3 months ago

Bausch Health reports Q4 EPS (30c) vs. 25c a year ago


NY AG announces settlement with Lannett and Bausch Health

2026-02-02T19:40:25.000Z - 3 months ago

NY AG announces settlement with Lannett and Bausch Health


Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Jan 23, 2026, 7:45 AM EST - 4 months ago

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials


Bausch Health price target raised to $8 from $7 at Truist

2026-01-07T12:20:14.000Z - 4 months ago

Bausch Health price target raised to $8 from $7 at Truist


Bausch Health initiated with an Equal Weight at Barclays

2025-12-08T21:31:57.000Z - 5 months ago

Bausch Health initiated with an Equal Weight at Barclays


Bausch Health rises 14.8%

2025-12-01T17:00:16.000Z - 5 months ago

Bausch Health rises 14.8%


Bausch Health rises 11.3%

2025-12-01T15:05:36.000Z - 5 months ago

Bausch Health rises 11.3%


Bausch Health launches offers to exchange senior secured notes

2025-11-24T12:50:20.000Z - 6 months ago

Bausch Health launches offers to exchange senior secured notes


Bausch + Lomb to Hold Investor Day on Nov. 13

Nov 3, 2025, 4:30 PM EST - 6 months ago

Bausch + Lomb to Hold Investor Day on Nov. 13


Bausch Health Companies Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

Bausch Health Companies Earnings Call Transcript: Q3 2025


Bausch Health Announces Third Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 7 months ago

Bausch Health Announces Third Quarter 2025 Results


Bausch + Lomb board members resign after Icahn agreement ends

Aug 18, 2025, 5:48 PM EDT - 9 months ago

Bausch + Lomb board members resign after Icahn agreement ends


Bausch Health Companies Earnings Call Transcript: Q2 2025

Jul 30, 2025, 5:00 PM EDT - 10 months ago

Bausch Health Companies Earnings Call Transcript: Q2 2025


Bausch Health Announces Second Quarter 2025 Results

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Bausch Health Announces Second Quarter 2025 Results


Bausch Health Appoints New Chief Accounting Officer

Jul 10, 2025, 4:15 PM EDT - 11 months ago

Bausch Health Appoints New Chief Accounting Officer


Rpate
Rpate May. 14 at 3:57 PM
$BHC BLCO showed negative free cash flow in Q1 2026 after two consecutive quarter of positive free cash flow. Now it may be possible BLCO can show negative free cash flow even after $7B revenue in 2028. Lot of noise about growth without positive free cash flow.
0 · Reply
Glene
Glene May. 14 at 12:30 AM
$BHC $DRRX how much are you figuring per share?
1 · Reply
bigbulldaddy
bigbulldaddy May. 13 at 11:02 PM
$BHC $DRRX Currently as of May Larsucosterol trial has 5/48 sites recruiting for 350 patient phase 3. Heads up to my people we are starting to move. Hope it’s quick. Good luck my LONG token holders… I did the math for myself: Assuming google is right I’m expecting… $288,000 at 500 million in sales $384,000 at 1 billion in sales Bausch is also looking at other R&D targets for Larsucosterol per info which we don’t get any money on… lol they literally called it REAHFIRM
1 · Reply
brunoq14
brunoq14 May. 13 at 2:51 AM
$BHC https://clinicaltrials.gov/study/NCT07428538 Three additional sites have begun recruiting for the larsucosterol trial, in Baltimore, Houston, and Richmond, joining Dallas and Charleston to make five in all. 48 sites are planned. Most recent update: 05/07/2026
0 · Reply
FU2
FU2 May. 11 at 10:44 PM
$BHC just total fuckery, heading to $5 again. Option traders are in full control. Hate these MM's to the core.
0 · Reply
truckersam
truckersam May. 11 at 8:27 PM
$BHC put 500,000 back in, we need the action 😁
0 · Reply
Bobberty
Bobberty May. 11 at 7:40 PM
$BHC and going sub $5 again. What a dumbass I am, should have kept it all in UNH. Oh well, get to enjoy the Canadian healthcare investment journey again.
0 · Reply
AnthonyNicholas
AnthonyNicholas May. 11 at 7:28 PM
$BHC what now why are we down so much today? 
0 · Reply
btradingwarehouse
btradingwarehouse May. 11 at 5:40 PM
$BHC ...2BULLS... ... ...Warriors ...We "lost" one of the most persistent bull (@SellSalix) ...His very classy update will be remembered ... ...Let's do quick reminder: ...You are NOT buying this beauty !!! ...Do NOT try to average unless you are trader (very good one) !!! ...You are NOT selling this beauty !!! ...Watch for BLCO ... Stay smart strong smile (if you can ?!)
0 · Reply
SellSalix
SellSalix May. 8 at 4:05 PM
$BHC it’s been a while, so I thought I would just update everyone. I sold this POS at a huge loss; about $500K. The opportunity cost on this probably adds another $500K (so, I effectively lost about a $1M). This is by far the worst investment I’ve ever made and it has scarred me for life. I did, however, end up buying long term calls at $5 and $10. If you are considering buying this stock, DON’T DO IT! Instead, buy call options that expire in a year or so. This is the only way to play this stock. I believe this will eventually re-rate once market comes to realize they will survive and monetize BLCO
8 · Reply
brunoq14
brunoq14 May. 7 at 11:13 AM
$BHC Anyone interested in the larsucosterol trial should check out the recent earnings presentation. In the question period, you will find a detailed description of how BHC is seeking to avoid the errors of the failed Durect trial, and why they are confident of success.
1 · Reply
Bobberty
Bobberty May. 6 at 2:18 PM
$BHC sold this two months ago and bought UNH. Since I apparently hate money I'm selling half of my UNH and getting back into this dog here. Still think she has a chance to shine again but it's a tough road ahead.
0 · Reply
Stock_Spectator
Stock_Spectator May. 1 at 3:38 PM
$BHC lower than before earnings…
0 · Reply
PenkeInvesting
PenkeInvesting May. 1 at 3:32 AM
Fundamental analysis of $BHC (Bausch Health Companies Inc.) based on financial data and reported results. #BHC
0 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 1:22 AM
$BHC Share Price: $5.72 Contract Selected: May 22, 2026 $5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.70 – $0.85 Potential Upside: 55% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
algomezus
algomezus Apr. 30 at 7:58 PM
$BHC this fucking pig is painful
0 · Reply
Stock_Spectator
Stock_Spectator Apr. 30 at 6:00 PM
$BHC and this will yet close red….
0 · Reply
AKTN
AKTN Apr. 30 at 4:41 PM
$BHC i don't see an impairment charge on the donut machine. Is this still in Appio's office? Or is it just dismantled sitting in the corner?
0 · Reply
btradingwarehouse
btradingwarehouse Apr. 30 at 4:26 PM
$BHC ...2BULLS... ...Champs ...You are NOT touching this !!! ...This COULD be many small props and strong individual traders trying to score on momentum !!! (my take) ...Please remember: without BLCO>$21 we ignore this beauty !!! ...Please remember: you are NOT selling one single share !!! ... Also we can try something VERY VERY VERY brave We all get together and buy 49 mil shares (2/3 of Mr. P holding ~$74 mil shares) With that we will break his control on this beauty and force him to let it go !!! ... Co. is simply PERFECT !!! ... Stay smart strong smile All good
0 · Reply
gary918
gary918 Apr. 30 at 2:53 PM
$BHC opt out law suits settled. That eliminates another big overhang
1 · Reply
FU2
FU2 Apr. 30 at 1:46 PM
$BHC probably a good time to short, always has a hard time holding g gains.
1 · Reply
greyfox
greyfox Apr. 30 at 12:02 AM
$BHC fake news as firing on all cylinders and this was an impairment charge...but then you have to read the numbers carefully and not rely on fake news from DJ
0 · Reply